You are on page 1of 5

Home > Laboratory Biosafety and Biosecurity > Biosafety Programs and Resources > Pathogen Safety Data

Sheets and Risk Assessment > Ancylostoma duodenale

ANCYLOSTOMA DUODENALE
PATHOGEN SAFETY DATA SHEET - INFECTIOUS SUBSTANCES
SECTION I - INFECTIOUS AGENT
NAME: Ancylostoma duodenale SYNONYM OR CROSS REFERENCE: Hookworm; Old World Hookworm (1, 2), intestinal nematode (1, 2), ground itch (1, 2), pruritic erythematous rash (1, 2), Ankylostomiasis, anchylostomiasis, ancylostomiasis, helminthiasis (3), miners' anemia (4), tunnel disease (4), uncinariasis (4), brickmaker's anemia (5). CHARACTERISTICS: A. duodenale belongs to the family Ancylostomatidae and subfamily of Ancylostomatinae (1). Adults are slightly larger and more robust than N. americanus. Adult male worm measures 8 to 11 by 0.4-0.5 mm, while the female is 10 to 13 mm long by 0.4-0.5 mm wide (1, 2). Their heads continue in the same direction as the curvature of their bodies (2, 6). Eggs are oval shaped with a thin shell and measure approximately 56-75 m by 36-40 m. They are characterized by a clear space between the developing embryo and the egg shell (1, 2). Eggs of N. americanus and A. duodenale are indistinguishable. Eggs are passed in feces and then embryonate and hatch within 1-2 days in soil as first stage rhabditoid larvae. First stage larvae develop to third stage, infectious, filariform larvae in approximately 1 week (1, 2, 7, 8).

SECTION II - HAZARD IDENTIFICATION


PATHOGENICITY/TOXICITY : Like N. americanus, A. duodenale (third-stage) larvae follow thermal gradients and are guided by heat to human skin where they may irritate or invade the skin (9). Like N. americanus, a pruritic, erythematous, papular rash develops and produces what is known as ground itch around penetration sites of the infective larvae, usually on the hands and feet (1, 2). Invasive infection occurs when larvae enter the bloodstream and are carried to the lungs. A mild cough and pharyngeal irritation may occur during larval migration in the airways; however, passage through the lungs is usually asymptomatic (10). The larvae are swallowed down the oesophagus and migrate to the gastrointestinal tract. Larvae then hook onto the intestinal mucosa where they mature into adult hookworms by feeding on blood. The major-hookworm related injury occurs due to intestinal blood loss, which can lead to iron-deficiency anaemia in moderate to heavy infections. In the gut, adult worms may produce epigastric pain and abnormal peristalsis (2, 6). Clinical features are highly dependent on worm burden and dietary iron levels (1, 2, 6). In children this condition may precipitate heart failure or kwashiorkor (1). Retardation of mental, sexual, and physical development has also been noted in children (1, 2, 7). Intrauterine growth retardation, prematurity, and low birth weight among newborns born to infected mothers has been noted (1, 7). Acute/heavy infections may result in fatigue, weakness, abdominal pain, and diarrhea with blood loss (1). Adults lifespan in human intestine is 1-2 years but can be as long as 10-12 years (1, 2, 6, 11). EPIDEMIOLOGY : Infections with A. duodenale frequently overlap N. americanus infections in areas of Africa, India and China. Estimated that approximately 740 million individuals are currently infected worldwide with A. duodenale and N. americanus (1, 2, 12, 13). Mortality rate, worldwide, attributed to deaths occurring through direct hookworm infection, is estimated to be ~65,000 deaths annually (14). The majority of infected individuals have a small worm burden and are asymptomatic (1, 2). Hookworm infection is among the most important tropical

oma duodenale 11/22/12 - Pathogen Saf ety Data Sheets - Public Health Agency of Canada

diseases in humans (7). Hookworm infection is found worldwide between 45N and 30S latitudes. A. duodenale is seen in Mediterranean basin, Middle East, sub-Saharan Africa, northern India, China, and Japan (1, 2, 6, 7). A. duodenale is endemic in warm, moist tropical areas where people defecate in the soil (6). Infection levels intensify in closed, densely populated communities such as tea and coffee plantations (2). HOST RANGE:Humans (15). INFECTIOUS DOSE: Unknown. MODE OF TRANSMISSION: Direct contact of soil containing filariform larvae with unprotected skin (1, 2, 6, 7). Infection can also be oral with direct maturation in the intestine to adult stage (1, 7). Infection can be transplacental or transmammary from mother to fetus/infant via infected placental/mammary tissue (16-18). INCUBATION PERIOD: Following penetration, A. duodenale migrates to the lungs within about 10 days (19). After 3 to 5 weeks, it passes through the gastrointestinal tract and attaches to the intestinal mucosa, where it matures into an adult worm and may stay for up to 1 year. Patent infections develop in 5-8 weeks following exposure (1, 2, 6). However, A. duodenale have the ability to arrest development in the host, this phenomenon can extend the prepatent period (20). COMMUNICABILITY : Human-to-human transmission: Mother to fetus/infant via infected placental/mammary tissue (11, 16-18).

SECTION III - DISSEMINATION


RESERVOIR: Humans are the only known reservoir of A.duodenale and N. americanus. The majority of infected individuals are asymptomatic due to low worm burden; however, eggs can be passed in feces (1, 2, 6, 7). ZOONOSIS: None. However, transfer of adult A. duodenale from infected dogs to a 3 year old child afflicted with congenital polycythemia has been reported (21). VECTORS: None.

SECTION IV - STABILITY AND VIABILITY


DRUG SUSCEPTIBILITY : A. duodenale is susceptible to pyrantel pamoate, mebendazole, nitrazoxanide, and albendazole (1, 2). SUSCEPTIBILITY TO DISINFECTANTS: Infective larvae of A. duodenale are susceptible to 70% ethanol for 10 minutes, 0.5 % Dettol for 20 minutes, chlorinated hydrocarbons (tetrachloroethylene) (22). Sodium hypochlorite (1%) and glutaraldehyde (2%) are not effective (22, 23). PHYSICAL INACTIVATION: Infective larvae are inactivated by the application of heat through water above 80C (practical recommendation is to use water that is close to boiling point) (22). Ancylostoma spp. larvae can not survive drying, or direct sunlight, and they cannot survive below 0 C or above 45 C (24). The larvae are also sensitive to high salt concentrations (25). SURVIVAL OUTSIDE HOST: Eggs hatch, releasing first stage rhabditiform larvae in soil, which develop into infectious, filariform larvae in 5-8 days (1, 2, 6, 7). Infectious, filariform larvae do not feed and if they fail to infect a host they die within a few weeks (2, 6). The infective filariform larvae remain viable in the soil for several weeks (1).

SECTION V FIRST AID / MEDICAL


SURVEILLANCE: Monitor for symptoms. Infection is demonstrated by direct observation of characteristic eggs in feces (1, 7). Quantitative egg counts include Kato-Katz test, concentration test, Beaver direct egg count, Stoll dilutional egg count, and McMaster techniques (26); and PCRwww.phac-aspc.gc.ca/lab-bio/res/psds-f tss/ancy lostoma-duodenale-eng.php 2/5

oma duodenale 11/22/12 - Pathogen Saf ety Data Sheets - Public Health Agency of Canada

based tests, with PCR-based tests being the most sensitive (26). FIRST AID/TREATMENT: Widely used antihelmintic agents pyrantel pamoate, mebendazole, and albendazole are highly effective in treating A. duodenale infection (1, 2, 6, 7). When anaemia is mild or moderate, iron replacement is often adequate treatment (1, 2, 6). More severe anaemia may require blood transfusions (1, 2). IMMUNISATION: Several vaccines are under development based on injection of combinations of isolated recombinant antigenic proteins (12-14, 27). PROPHYLAXIS: Hygiene measures such as hand washing, drinking safe water, properly cleaning and cooking food, and wearing shoes (10).

SECTION VI - LABORATORY HAZARDS


LABORATORY-ACQUIRED INFECTIONS: None reported for A. duodenale. One case of ground itch reported in an animal caretaker treating cat infected with Ancylostoma braziliense and Ancylostoma caninum Close relatives of A. duodenale (28, 29). SOURCES/SPECIMENS: Stool (1, 2, 6, 7), infected tissue (20), infected soil (1, 2, 6, 7). PRIMARY HAZARDS: Direct contact via unprotected skin or oral mucosa with infected materials (1, 2, 6, 7), accidental inoculation (28). SPECIAL HAZARDS: None.

SECTION VII EXPOSURE CONTROLS / PERSONAL PROTECTION


RISK GROUP CLASSIFICATION: Risk Group 2. CONTAINMENT REQUIREMENTS: Containment Level 2 facilities, equipment, and operational practices for work involving infectious or potentially infectious materials, animals, or cultures (30). PROTECTIVE CLOTHING: Lab coat. Gloves when direct skin contact with infected materials or animals is unavoidable. Eye protection must be used where there is a known or potential risk of exposure to splashes (30). OTHER PRECAUTIONS: All procedures that may produce aerosols, or involve high concentrations or large volumes should be conducted in a biological safety cabinet (BSC). The use of needles, syringes, and other sharp objects should be strictly limited. Additional precautions should be considered with work involving animals or large scale activities (30).

SECTION VIII HANDLING AND STORAGE


SPILLS: Allow aerosols to settle and, wearing protective clothing, gently cover spill with paper towels and apply an appropriate disinfectant, starting at the perimeter and working towards the centre. Allow sufficient contact time before clean up (30, 31). DISPOSAL: Decontaminate all wastes that contain or have come in contact with the infectious organism by autoclave, chemical disinfection, gamma irradiation, or incineration before disposing (30). STORAGE: The infectious agent should be stored in leak-proof containers that are appropriately labelled (30).

SECTION IX - REGULATORY AND OTHER INFORMATION


UPDATED: December 2011 PREPARED BY : Pathogen Regulation Directorate, Public Health Agency of Canada. Although the information, opinions and recommendations contained in this Pathogen Safety Data
www.phac-aspc.gc.ca/lab-bio/res/psds-f tss/ancy lostoma-duodenale-eng.php 3/5

oma duodenale 11/22/12 - Pathogen Saf ety Data Sheets - Public Health Agency of Canada

Sheet are compiled from sources believed to be reliable, we accept no responsibility for the accuracy, sufficiency, or reliability or for any loss or injury resulting from the use of the information. Newly discovered hazards are frequent and this information may not be completely up to date. Copyright Public Health Agency of Canada, 2011 Canada

REFERENCES:
1. Sheorey, H., Biggs, B. A., & Traynor, P. (2007). Nematodes. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry & M. A. Pfaller (Eds.), Manual of Clinical Microbiology (9th ed., pp. 2144-2155.). Washington, D.C.: ASM press. 2. Plourde, J. J. (2004). Intestinal Nematodes. In K. J. Ryan, & C. G. Ray (Eds.), Sherris Medical Microbiology: An Introduction to Infectious Disease (4th ed., pp. 763-777). USA: McGraw-Hill. 3. Loughlin, E. H., & Spitz, S. H. (1949). Diagnosis of Helminthiasis. JAMA: The Journal of the American Medical Association, 139(15), 997-1000. 4. A Factor in the Anemia of Uncinariasis. (1904). JAMA: The Journal of the American Medical Association, XLIII(12), 817-b. 5. Bozzolo, C. (1912). Notes on the Treatment of Ankylostoma Anemia (uncinariasis, hookworm disease) with Thymol. JAMA: The Journal of the American Medical Association, LVIII(23), 17441746. 6. Cross, J. H. (1996). Enteric Nematodes of Humans in Medical Microbiology. In Baron S. et al. (Ed.), (4th Edition ed., ). Galveston: The University of Texas Medical Branch. 7. Hotez, P. J., Brooker, S., Bethony, J. M., Bottazzi, M. E., Loukas, A., & Xiao, S. (2004). Hookworm infection. New England Journal of Medicine, 351(8), 799-807. 8. Collins, C. H., & Kennedy, D. A. (1999). Endoparasites. Laboratory-acquired Infections: History, incidence, causes, and prevention (4th ed., pp. 253-255). Oxford: Butterworth Heimann. 9. Haas, W., Haberl, B., Syafruddin, Idris, I., Kallert, D., Kersten, S., Stiegeler, P., & Syafruddin. (2005). Behavioural strategies used by the hookworms Necator americanus and Ancylostoma duodenale to find, recognize and invade the human host. Parasitology Research, 95(1), 30-39. doi:10.1007/s00436-004-1257-7 10. Weller, P. R., & Leder, K.Hookworm infection. www.uptodate.com 11. Brooker, S., Bethony, J., & Hotez, P. J. (2004). Human hookworm infection in the 21st century. Advances in Parasitology, 58, 197-288. 12. Hotez, P. J., Le Trang, N., & Cerami, A. (1987). Hookworm antigens: the potential for vaccination. Parasitology Today, 3(8), 247-249. 13. Hotez, P. J., Zhan, B., Bethony, J. M., Loukas, A., Williamson, A., Goud, G. N., Hawdon, J. M., Dobardzic, A., Dobardzic, R., Ghosh, K., Bottazzi, M. E., Mendez, S., Zook, B., Wang, Y., Liu, S., Essiet-Gibson, I., Chung-Debose, S., Xiao, S., Knox, D., Meagher, M., Inan, M., Correa-Oliveira, R., Vilk, P., Shepherd, H. R., Brandt, W., & Russell, P. K. (2003). Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative. International Journal for Parasitology, 33(11), 1245-1258. 14. Diemert, D. J., Bethony, J. M., & Hotez, P. J. (2008). Hookworm vaccines. Clinical Infectious Diseases, 46(2), 282-288. 15. American Academy of Pediatrics.Committee on Infectious Diseases. (2009). Red book (28th ed.). Elk Grove Village, IL: American Academy of Pediatrics. Retrieved from http://online.statref.com/document.aspx?FxId=76&DocID=1&grpalias=
www.phac-aspc.gc.ca/lab-bio/res/psds-f tss/ancy lostoma-duodenale-eng.php

oma duodenale 11/22/12 - Pathogen Saf ety Data Sheets - Public Health Agency of Canada

16. Hotez, P. J. (1989). Hookworm disease in children. Pediatric Infectious Disease Journal, 8(8), 516-520. 17. Yu, S. H., Jiang, Z. X., & Xu, L. Q. (1995). Infantile hookworm disease in China. A review. Acta Tropica, 59(4), 265-270. 18. Brooker, S., Hotez, P. J., & Bundy, D. A. (2008). Hookworm-related anaemia among pregnant women: a systematic review. PLoS Neglected Tropical Diseases [Electronic Resource], 2(9), e291. 19. Sheorey, H., Biggs, B. A., & Traynor, P. (2007). Nematodes. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry & M. A. Pfaller (Eds.), Manual of Clinical Microbiology (9th ed., pp. 2144-2155). Washington, USA: ASM Press. 20. Schad, G. A., Murrell, K. D., Fayer, R., El Naggar, H. M. S., Page, M. R., Parrish, P. K., & Stewart, T. B. (1984). Paratenesis in Ancylostoma duodenale suggests possible meat-borne human infection. Transactions of the Royal Society of Tropical Medicine and Hygiene, 78(2), 203-204. 21. Walterspiel, J. N., Schad, G. A., & Buchanan, G. R. (1984). Direct transfer of adult hookworms (Ancylostoma duodenale) from dog to child for therapeutic purposes. Journal of Parasitology, 70(2), 217-219. 22. Speare, R., Melrose, W., Cooke, S., & Croese, J. (2008). Techniques to kill infective larvae of human hookworm Necator americanus in the laboratory and a new Material Safety Data Sheet. Australian Journal of Medical Science, 29(3), 91-96. 23. Ayek, H., Yarsan, E., Ouz Sarimehmetolu, H., Tanyksel, M., Grgnkardeler, N., & zyurt, M. (2001). Efficacy of Some Disinfectants on Embryonated Eggs of Toxocara canis. Turk J Med Sci, 31(1), 35-39. 24. Menelaos, L. A., & Smaragda, K. E. (2006). Prevalence of hookworm parasites in dog from the area of Thessaloniki and their zoonotic importance. Buletin USAMV-CN, 63, 297-303. 25. Pawlowski, Z. S., Schad, G. A., & Stott, G. J. (1991). Epidemiology of hookworm infection. Hookworm infection and anaemia: Approaches to prevention and control (). Geneva: World Health Organization. 26. Pawlowski Z.S., Schad G.A., Stott G.J. (1991). Hookworm infection and anaemia : approaches to prevention and control. Geneva: World Health Organization. 27. Hawdon, J. M., & Hotez, P. J. (1996). Hookworm: developmental biology of the infectious process. Current Opinion in Genetics & Development, 6(5), 618-623. 28. Herwaldt, B. L. (2001). Laboratory-acquired parasitic infections from accidental exposures. Clinical Microbiology Reviews, 14(4), 659-688. 29. Stone, O. J., & Levy, A. (1967). Creeping eruption in an animal caretaker. Laboratory Animal Care, 17(5), 479-482. 30. Public Health Agency of Canada. (2004). In Best M., Graham M. L., Leitner R., Ouellette M. and Ugwu K. (Eds.), Laboratory Biosafety Guidelines (3rd ed.). Canada: Public Health Agency of Canada. 31. Burnett, L. A. C., Lunn, G., & Coico, R. (2009). Biosafety: Guidelines for working with pathogenic and infectious microorganisms. Current Protocols in Microbiology, (SUPPL. 13), 1A.1.1-1A.1.14. Date Modified: 2012-04-30

www.phac-aspc.gc.ca/lab-bio/res/psds-f tss/ancy lostoma-duodenale-eng.php

5/5